Multiple Molecular Data Sets and the Classification of Adult Diffuse Gliomas

In these days of individualized precision medicine and “big data” generated by means of next-generation sequencing, there are expectations that new therapeutic strategies for cancer will be quickly conceived and then realized in the clinic. Next-generation sequencing has certainly provided new insights into some cancers, stimulating the study of underlying biologic mechanisms and the development of targeted treatments. But even when whole-genome...